Stock Traders Buy High Volume of Call Options on ICU Medical (NASDAQ:ICUI)

Share on StockTwits

ICU Medical, Incorporated (NASDAQ:ICUI) was the target of unusually large options trading activity on Tuesday. Stock traders acquired 988 call options on the stock. This is an increase of approximately 1,105% compared to the typical daily volume of 82 call options.

Shares of ICUI opened at $175.18 on Thursday. ICU Medical has a twelve month low of $148.89 and a twelve month high of $259.72. The firm’s 50 day moving average price is $159.56 and its two-hundred day moving average price is $201.44. The firm has a market cap of $3.46 billion, a P/E ratio of 22.72 and a beta of 0.91.

ICU Medical (NASDAQ:ICUI) last announced its quarterly earnings results on Monday, November 11th. The medical instruments supplier reported $1.65 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.62 by $0.03. ICU Medical had a net margin of 3.56% and a return on equity of 12.41%. The firm had revenue of $307.47 million for the quarter, compared to analyst estimates of $297.83 million. During the same quarter in the previous year, the firm posted $1.85 earnings per share. The business’s revenue was down 6.0% on a year-over-year basis. As a group, research analysts forecast that ICU Medical will post 7.21 EPS for the current year.

Several research firms recently weighed in on ICUI. ValuEngine raised shares of ICU Medical from a “sell” rating to a “hold” rating in a research note on Wednesday, October 2nd. Raymond James lifted their price target on shares of ICU Medical from $185.00 to $203.00 and gave the company a “positive” rating in a research note on Tuesday. BidaskClub raised shares of ICU Medical from a “sell” rating to a “hold” rating in a research note on Friday, October 25th. TheStreet lowered shares of ICU Medical from a “b-” rating to a “c+” rating in a research note on Monday, August 12th. Finally, Zacks Investment Research lowered shares of ICU Medical from a “hold” rating to a “sell” rating in a research note on Wednesday, August 14th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and one has given a buy rating to the stock. ICU Medical presently has an average rating of “Hold” and an average target price of $242.00.

In related news, Director Robert S. Swinney sold 373 shares of ICU Medical stock in a transaction that occurred on Monday, October 14th. The shares were sold at an average price of $153.49, for a total transaction of $57,251.77. Following the transaction, the director now owns 18,845 shares of the company’s stock, valued at approximately $2,892,519.05. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, VP Virginia Ruth Sanzone sold 3,000 shares of ICU Medical stock in a transaction that occurred on Wednesday, September 4th. The stock was sold at an average price of $154.08, for a total transaction of $462,240.00. Following the transaction, the vice president now directly owns 55 shares in the company, valued at approximately $8,474.40. The disclosure for this sale can be found here. 11.40% of the stock is owned by company insiders.

A number of institutional investors and hedge funds have recently made changes to their positions in the business. Municipal Employees Retirement System of Michigan raised its holdings in shares of ICU Medical by 1.3% in the second quarter. Municipal Employees Retirement System of Michigan now owns 3,070 shares of the medical instruments supplier’s stock valued at $773,000 after purchasing an additional 40 shares during the last quarter. Advisory Services Network LLC raised its holdings in shares of ICU Medical by 70.2% in the second quarter. Advisory Services Network LLC now owns 143 shares of the medical instruments supplier’s stock valued at $36,000 after purchasing an additional 59 shares during the last quarter. Huntington National Bank raised its holdings in shares of ICU Medical by 15.3% in the second quarter. Huntington National Bank now owns 474 shares of the medical instruments supplier’s stock valued at $119,000 after purchasing an additional 63 shares during the last quarter. Oregon Public Employees Retirement Fund raised its holdings in shares of ICU Medical by 1.4% in the second quarter. Oregon Public Employees Retirement Fund now owns 6,741 shares of the medical instruments supplier’s stock valued at $1,698,000 after purchasing an additional 95 shares during the last quarter. Finally, Retirement Systems of Alabama raised its holdings in shares of ICU Medical by 0.5% in the second quarter. Retirement Systems of Alabama now owns 21,718 shares of the medical instruments supplier’s stock valued at $5,471,000 after purchasing an additional 103 shares during the last quarter. 94.04% of the stock is currently owned by hedge funds and other institutional investors.

About ICU Medical

ICU Medical, Inc develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein.

Further Reading: What are different types of coverage ratios?

Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.